These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25187092)

  • 1. Canagliflozin-Associated Acute Pancreatitis.
    Verma R
    Am J Ther; 2016; 23(3):e972-3. PubMed ID: 25187092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study.
    Yuan Z; DeFalco F; Wang L; Hester L; Weaver J; Swerdel JN; Freedman A; Ryan P; Schuemie M; Qiu R; Yee J; Meininger G; Berlin JA; Rosenthal N
    Curr Med Res Opin; 2020 Jul; 36(7):1117-1124. PubMed ID: 32338068
    [No Abstract]   [Full Text] [Related]  

  • 3. Sodium-glucose cotransporter 2 inhibitors and diabetic ketoacidosis.
    Bloomgarden ZT
    J Diabetes; 2016 Mar; 8(2):175-6. PubMed ID: 26611882
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus.
    Watts NB; Bilezikian JP; Usiskin K; Edwards R; Desai M; Law G; Meininger G
    J Clin Endocrinol Metab; 2016 Jan; 101(1):157-66. PubMed ID: 26580237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetic ketoacidosis with mild hyperglycemia associated with the use of canagliflozin. Report of one case with type 1 diabetes].
    Novik A V; García B C; Oliva I D
    Rev Med Chil; 2017 Mar; 145(3):393-396. PubMed ID: 28548198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic ketoacidosis associated to canagliflozin in type 2 diabetes.
    González Sanchidrián S; Gómez-Martino Arroyo JR; Labrador Gómez PJ
    Med Clin (Barc); 2017 Feb; 148(4):e19-e20. PubMed ID: 28041622
    [No Abstract]   [Full Text] [Related]  

  • 7. ‘Euglycemic’ Ketoacidosis in a Patient With Type 2 Diabetes Being Treated With Canagliflozin.
    Danford C; Chan P; Magill SB
    WMJ; 2016 Aug; 115(4):206-9. PubMed ID: 29099159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Euglycemic Ketoacidosis Caused by Sodium-Glucose Cotransporter 2 Inhibitors: A Case Report.
    Bobart SA; Gleason B; Martinez N; Norris K; Williams SF
    Ann Intern Med; 2016 Oct; 165(7):530-532. PubMed ID: 27699391
    [No Abstract]   [Full Text] [Related]  

  • 9. Canagliflozin: a new option for managing diabetes.
    Livingston M; Clements JN
    JAAPA; 2014 Sep; 27(9):47-50. PubMed ID: 25148443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Euglycemic diabetic ketoacidosis with canagliflozin: Not-so-sweet but avoidable complication of sodium-glucose cotransporter-2 inhibitor use.
    Clement M; Senior P
    Can Fam Physician; 2016 Sep; 62(9):725-8. PubMed ID: 27629668
    [No Abstract]   [Full Text] [Related]  

  • 11. Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimization.
    Khurana M; Vaidyanathan J; Marathe A; Mehrotra N; Sahajwalla CG; Zineh I; Jain L
    J Clin Pharmacol; 2015 Jun; 55(6):647-56. PubMed ID: 25612234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quiz: Metabolic Acidosis in a Patient With Type 2 Diabetes.
    Kohli J; Goldfarb S
    Am J Kidney Dis; 2017 Jun; 69(6):A11-A13. PubMed ID: 28532637
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized Intense Pruritus During Canagliflozin Treatment: Is it an Adverse Drug Reaction?
    Vasapollo P; Cione E; Luciani F; Gallelli L
    Curr Drug Saf; 2018; 13(1):38-40. PubMed ID: 27048192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Severe diabetic ketoacidosis, acute kidney injury and dehydration due to canagliflozin in type 2 diabetes mellitus patient: Atypical clinical presentation].
    Moreno Obregón F; Espino Montoro A; Marín Martín J; León Jiménez D
    Aten Primaria; 2019 Dec; 51(10):664-666. PubMed ID: 31326123
    [No Abstract]   [Full Text] [Related]  

  • 15. Normoglycemic ketoacidosis in a postoperative gastric bypass patient taking canagliflozin.
    Bonanni FB; Fei P; Fitzpatrick LL
    Surg Obes Relat Dis; 2016 Jan; 12(1):e11-2. PubMed ID: 26686305
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and tolerability of canagliflozin in patients with type 2 diabetes mellitus: pooled analysis of phase 3 study results.
    Usiskin K; Kline I; Fung A; Mayer C; Meininger G
    Postgrad Med; 2014 May; 126(3):16-34. PubMed ID: 24918789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus.
    Rosenthal N; Meininger G; Ways K; Polidori D; Desai M; Qiu R; Alba M; Vercruysse F; Balis D; Shaw W; Edwards R; Bull S; Di Prospero N; Sha S; Rothenberg P; Canovatchel W; Demarest K
    Ann N Y Acad Sci; 2015 Nov; 1358():28-43. PubMed ID: 26305874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium-glucose cotransporter 2 inhibitor-associated diabetic ketoacidosis: Report of two cases with hyperglycemic ketoacidosis in type 1 diabetes.
    Harati H; Sharma V; Motazedi A
    J Diabetes; 2016 Jan; 8(1):165. PubMed ID: 26211700
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic Acidosis in Postsurgical Patient on Canagliflozin and Metformin: A Case Report.
    Darwish AM
    A A Pract; 2019 Apr; 12(7):221-222. PubMed ID: 30234515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exenatide and acute pancreatitis.
    Tripathy NR; Basha S; Jain R; Shetty S; Ramachandran A
    J Assoc Physicians India; 2008 Dec; 56():987-8. PubMed ID: 19322980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.